Immunotherapy drug doubles cancer-free survival in head and neck cancer patients
BBC - 31-May-2025Pembrolizumab doubled cancer-free survival from 2.5 to 5 years and cut spread risk by 10%
Head and Neck Cancer
Head and Neck Cancer News
Head and Neck Cancer Resources
No resources found!
Head and Neck Cancer Blog Posts
No blog posts found!
